Target intelligence / Profile preview

DBI pseudogene 2 (DBIP2)

Target
DBIP2
Molecular classification
Other (Pseudogene, Non-coding RNA)
01

Overview

DBI pseudogene 2 (DBIP2) is a processed pseudogene, meaning it is derived from the reverse transcription of mRNA from the parent DBI gene and lacks the ability to encode a functional protein. Pseudogenes like DBIP2 are typically non-functional as protein-coding genes due to mutations disrupting their coding potential or regulatory sequences, and there is no evidence that DBIP2 acts as a functional gene or therapeutic target. While some pseudogenes can play roles in gene regulation or disease, there is no published evidence for any specific biological or disease-related function for DBIP2. Key points explaining "is_incorrect": - DBIP2 is a pseudogene with no evidence of protein-coding ability. - It is not recognized as a canonical therapeutic target, such as a receptor, enzyme, transporter, or signaling molecule. - No functional, disease, or pharmacological information specific to DBIP2 is described in available references. Summary: DBI pseudogene 2 (DBIP2) is a processed pseudogene with no documented role in protein function, signaling, or therapeutic targeting. It is best classified as a genomic pseudogene locus with no established biomedical relevance.

Other names
DBIL1
02

Mechanism of action

None

03

Biological functions

Not establishedPseudogenes rarely encode protein or canonical functions. Possible involvement in gene regulation (epigenetic regulation, post-transcriptional gene regulation, modulation of parental gene expression applies broadly to some pseudogenes, but specific function for DBIP2 is not reported)
04

Disease associations

None establishedNo disease association or involvement as a therapeutic or diagnostic target for DBIP2 is reported.

Beyond the preview

Go deeper on DBI pseudogene 2 (DBIP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DBI pseudogene 2 (DBIP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call